Macrophage polarization in interstitial lung diseases

Central European Journal of Immunology

Volumn 41, Issue 2, 2016, Pages 159-164

  Wojtan, Pawel ^a   Mierzejewski, Michal ^a   Osiñska, Iwona ^a   Domagala Kulawik, Joanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Bal; CD163; CD40; Interstitial lung disease; Macrophages M1; Macrophages M2; Sarcoidosis

Indexed keywords

CD163 ANTIGEN; CD40 ANTIGEN;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CELL SPECIFICITY; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; IMMUNOCYTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLARIZATION; SARCOIDOSIS;

EID: 84978645314     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2016.60990     Document Type: Article

References (32)

1. Meyer KC, Raghu G, Baughman RP, et al. (2012): An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185: 1004-1014.
2. Chcialowski A, Chorostowska-Wynimko J, Fal A, et al. (2011): Recommendation of the Polish Respiratory Society for bronchoalveolar lavage (BAL) sampling, processing and analysis methods. Pneumonol Alergol Pol 79: 75-89.
3. Domagala-Kulawik J, Skirecki T, Maskey-Warzechowska M, et al. (2012): Bronchoalveolar lavage total cell count in interstitial lung diseases-does it matter? Inflammation 35: 803-809.
4. Domagala-Kulawik J, Maskey-Warzechowska M, Krenke R, et al. (2008): Role of bronchoalveolar lavage in the initial diagnosis of smoking-related interstitial lung diseases. J Physiol Pharmacol 59 Suppl 6: 243-251.
5. Mackaness GB. (1964): The Immunological Basis of Acquired Cellular Resistance. J Exp Med 120: 105-120.
6. Schwartz Y, Svistelnik AV (2012): Functional phenotypes of macrophages and the M1-M2 polarization concept. Part I. Proinflammatory phenotype. Biochemistry (Mosc) 77: 246-260.
7. Sica A, Mantovani A (2012): Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795.
8. Ino Y, Yamazaki-Itoh R, Shimada K, et al. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer 2013; 108: 914-923.
9. Aron-Wisnewsky J, Tordjman J, Poitou C, et al. (2009): Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 94: 4619-4623.
10. Verreck FA, de Boer T, Langenberg DM, et al. (2006): Phe-notypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma-and CD40L-mediated costimulation. J Leukoc Biol 79: 285-293.
11. Van Gorp H, Delputte PL, Nauwynck HJ (2010): Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol Immunol 47: 1650-1660.
12. Kowal K, Silver R, Slawinska E, et al. (2011): CD163 and its role in inflammation. Folia Histochem Cytobiol 49: 365-374.
13. Edin S, Wikberg ML, Dahlin AM, et al. (2012): The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One 7: e47045.
14. Barros MH, Hauck F, Dreyer JH, et al. (2013): Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One 8: e80908.
15. Vogel DY, Vereyken EJ, Glim JE, et al. (2013): Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation 10: 35.
16. Kunz LI, Lapperre TS, Snoeck-Stroband JB, et al. (2011): Smoking status and anti-inflammatory macrophages in bron-choalveolar lavage and induced sputum in COPD. Respir Res 12: 34.
17. Osinska I, Wolosz D, Domagala-Kulawik J (2014): Association between M1 and M2 macrophages in bronchoalveolar lavage fluid and tobacco smoking in patients with sarcoidosis. Pol Arch Med Wewn 124: 359-364.
18. Hibbs JB Jr (2002): Infection and nitric oxide. J Infect Dis 185 Suppl 1: S9-17.
19. Cassetta L, Cassol E, Poli G (2011): Macrophage polarization in health and disease. Scientific World Journal 11: 2391-2402.
20. Travis WD, Costabel U, Hansell DM, et al. (2013): An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188: 733-748.
21. Italiani P, Boraschi D. From Monocytes to M1/M2 Macro-phages: Phenotypical vs. Functional Differentiation. Front Immunol 2014; 5: 514.
22. Martinez FO, Gordon S, Locati M, et al. (2006): Transcrip-tional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177: 7303-7311.
23. Suttles J, Stout RD (2009): Macrophage CD40 signaling: a pivotal regulator of disease protection and pathogenesis. Semin Immunol 2009; 21: 257-264.
24. Domagala-Kulawik J, Droszcz P, Kraszewska I, et al. (2000): Expression of Fas antigen in the cells from bronchoalveolar lavage fluid (BALF). Folia Histochem Cytobiol 38: 185-188.
25. Hodge S, Hodge G, Ahern J, et al. (2007): Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 37: 748-755.
26. Pechkovsky DV, Prasse A, Kollert F, et al. (2010): Alternatively activated alveolar macrophages in pulmonary fibro-sis-mediator production and intracellular signal transduction. Clin Immunol 137: 89-101.
27. Redente EF, Higgins DM, Dwyer-Nield LD, et al. (2010): Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol 88: 159-168.
28. Wikén M, Al Hayja MA, Grunewald J, et al. (2010): No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis. Respir Res 11: 121.
29. Misson P, van den Brule S, Barbarin V, et al. (2004): Markers of macrophage differentiation in experimental silicosis. J Leukoc Biol 76: 926-932.
30. Renzoni E, Srihari V, Sestini P (2014): Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings. F1000Prime Rep 6: 69.
31. Mills CD, Kincaid K, Alt JM, et al. (2000): M-1/M-2 mac-rophages and the Th1/Th2 paradigm. J Immunol 164: 6166-6173.
32. Mathai SK, Gulati M, Peng X, et al. (2010): Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 90: 812-823.